| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |